Neurodevelopmental features in KCNQ2 developmental and epileptic encephalopathy may have limited associations with K<sub>V</sub>7.2 dysfunction. [PDF]
Bidwell JS +4 more
europepmc +1 more source
Impact of vigabatrin on risk of relapse of infantile spasms
Abstract Objective Vigabatrin is an effective treatment for infantile epileptic spasms syndrome (IESS), but relapse remains a clinical challenge. The ideal dose and duration of treatment after response are unknown. We set out to identify treatment‐related predictors of IESS relapse after initial vigabatrin response. Methods We conducted a retrospective
Yaretson I. Carmenate +5 more
wiley +1 more source
Aminopyridine treatment for an adult patient of developmental and epileptic encephalopathy with a gain-of-function mutation in KCNA2. [PDF]
Gao L, Jia Y, Yang Y, Chen J, Ren L.
europepmc +1 more source
This graphical abstract provides an overview of the content from this post hoc analysis evaluating the efficacy and safety of fenfluramine in patients with Dravet syndrome stratified by age, number of previously attempted antiseizure medications, and SCN1A pathogenic variant status using data pooled from the three pivotal randomized controlled trials ...
Rima Nabbout +20 more
wiley +1 more source
Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas. [PDF]
Wagner K +9 more
europepmc +1 more source
Abstract Objective Stiripentol and fenfluramine are approved treatments for Dravet syndrome (DS), but real‐world data comparing their effectiveness and combined use remain limited. Our study aims to explore associations between treatment with stiripentol, fenfluramine, and their combination and clinical outcomes in patients with DS.
Paolo Surdi +7 more
wiley +1 more source
Knockdown-Replace: A New Dynamic for Treatment of Dynamin-1 Related developmental and epileptic encephalopathy (DEE). [PDF]
Wagnon JL.
europepmc +1 more source
Abstract Objective Sudden Unexpected Death in Epilepsy (SUDEP) is the leading cause of epilepsy‐related mortality, particularly in individuals with Developmental and Epileptic Encephalopathies (DEEs). The goal of this work is to assess SUDEP‐related knowledge, information practices, emotional and psychological impact, and the use of preventive measures
José Ángel Aibar +8 more
wiley +1 more source
Potassium current inactivation as a novel pathomechanism for KCNQ2 developmental and epileptic encephalopathy. [PDF]
Gaspar IL +6 more
europepmc +1 more source
Fenfluramine in Rett syndrome: A multidimensional clinical study
Abstract Objective Rett syndrome (RTT) is a severe neurodevelopmental disorder frequently associated with drug‐resistant epilepsy, autonomic dysfunction, respiratory abnormalities, sleep disturbances, and behavioral impairment. Fenfluramine has shown efficacy in developmental and epileptic encephalopathies and may provide broader therapeutic benefits ...
Elena Gonzalez‐Alguacil +11 more
wiley +1 more source

